Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 29th Edition (2009) PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 29th Edition (2009) PDF full book. Access full book title Approved Drug Products with Therapeutic Equivalence Evaluations - FDA Orange Book 29th Edition (2009) by Food and Drug Administration. Download full books in PDF and EPUB format.
Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 1934899798
Category : Medical
Languages : en
Pages : 1161
Get Book Here
Book Description
FDA Orange Book 29th Edition - 2009 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 1934899798
Category : Medical
Languages : en
Pages : 1161
Get Book Here
Book Description
FDA Orange Book 29th Edition - 2009 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 1934899801
Category : Medical
Languages : en
Pages : 1115
Get Book Here
Book Description
FDA Orange Book 30th Edition - 2010 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 193489981X
Category : Medical
Languages : en
Pages : 1253
Get Book Here
Book Description
FDA Orange Book 31st Edition - 2011 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899852
Category : Medical
Languages : en
Pages : 100
Get Book Here
Book Description
NESINA Drug Profile, 2023
This report focuses on NESINA and covers the following critical aspects of this drug:
- United States patents
- Expired United States patents
- FDA Paragraph IV patent challenges
- District Court patent litigation
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Finished product suppliers
- Raw active pharmaceutical ingredient (API) sources
Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 1934899828
Category : Medical
Languages : en
Pages : 1299
Get Book Here
Book Description
FDA Orange Book 32nd Edition - 2012 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 193489978X
Category : Medical
Languages : en
Pages : 1103
Get Book Here
Book Description
FDA Orange Book 28th Edition - 2008 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author: DrugPatentWatch
Publisher: DrugPatentWatch.com
ISBN: 1934899836
Category : Medical
Languages : en
Pages : 101
Get Book Here
Book Description
MOVIPREP Drug Profile, 2023
This report focuses on MOVIPREP and covers the following critical aspects of this drug:
- United States patents
- FDA Paragraph IV patent challenges
- District Court patent litigation
- European supplementary protection certificates (SPCs)
- Clinical trials
- Drug prices
- Annual sales revenues
- Finished product suppliers
Author: Food and Drug Administration
Publisher: DrugPatentWatch.com
ISBN: 1934899755
Category : Medical
Languages : en
Pages : 1039
Get Book Here
Book Description
FDA Orange Book 25th Edition - 2005 (Approved Drug Products With Therapeutic Equivalence Evaluations)
Author: Isadore Kanfer
Publisher: CRC Press
ISBN: 1420020021
Category : Medical
Languages : en
Pages : 334
Get Book Here
Book Description
Due to a worldwide need for lower cost drug therapy, use of generic and multi-source drug products have been increasing. To meet international patent and trade agreements, the development and sale of these products must conform to national and international laws, and generic products must prove that they are of the same quality and are therapeutica
Author: Antoine Al-Achi
Publisher: John Wiley & Sons
ISBN: 0470596929
Category : Medical
Languages : en
Pages : 1024
Get Book Here
Book Description
Focusing on the application of physical pharmacy, drug design, and drug regulations as they relate to produce effective dosage forms for drug delivery, Integrated Pharmaceutics provides a comprehensive picture of pharmaceutical product design, describing the science and art behind the concepts of dosage form development. Combining physical pharmacy, product design, and regulatory affairs issues in a single book, the authors address topics governing drug regulations of United States, European, and Japanese agencies and detail new regulatory guidelines, including quality by design, design space analysis, and blend sample uniformity.
